Transduction with human telomerase reverse transcriptase immortalizes a rhesus macaque CD8+ T cell clone with maintenance of surface marker phenotype and function

AIDS Research and Human Retroviruses

Volumn 23, Issue 3, 2007, Pages 456-465

  Andersen, Hanne ^a,c   Barsov, Eugene V ^a   Trivett, Matthew T ^a   Trubey, Charles M ^a   Giavedoni, Luis D ^b   Lifson, Jeffrey D ^a   Ott, David E ^a   Öhlén, Claes ^a  

^a SAIC FREDERICK INC   (United States)

^b SOUTHWEST NATIONAL PRIMATE RESEARCH CENTER   (United States)

^c BIOQUAL INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETROVIRUS VECTOR; TELOMERASE REVERSE TRANSCRIPTASE;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ARTICLE; CD8+ T LYMPHOCYTE; CELL CLONE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOLYSIS; ENZYME ANALYSIS; IMMUNOSTIMULATION; MACACA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SENESCENCE; SIGNAL TRANSDUCTION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CLONE CELLS; FEMALE; HUMANS; MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, CYTOTOXIC; TELOMERASE; TRANSDUCTION, GENETIC;

EID: 34247281402     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.0194     Document Type: Article

References (42)

1. Weng NP, Palmer LD, Levine BL, Lane HC, June CH, and Hodes RJ: Tales of tails: Regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging. Immunol Rev 1997;160:43-54.
2. Perillo NL, Walford RL, Newman MA, and Effros RB: Human T lymphocytes possess a limited in vitro life span. Exp Gerontol 1989;24(3):177-187.
3. Roth A, Yssel H, Pene J, et al.: Telomerase levels control the lifespan of human T lymphocytes. Blood 2003;102(3):849-857.
4. Hooijberg E, Ruizendaal JJ, Snijders PJ, Kueter EW, Walboomers JM, and Spits H: Immortalization of human CD8+ T cell clones by ectopic expression of telomerase reverse transcriptase. J Immunol 2000;165(8):4239-4245.
5. Dagarag M, Evazyan T, Rao N, and Effros RB: Genetic manipulation of telomerase in HIV-specific CD8+ T cells: Enhanced antiviral functions accompany the increased proliferative potential and telomere length stabilization. J Immunol 2004;173(10):6303-6311.
6. Zhou J, Shen X, Huang J, Hodes RJ, Rosenberg SA, and Robbins PF: Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy. J Immunol 2005;175(10):7046-7052.
7. Barsov EV, Andersen H, Coalter VJ, Carrington M, Lifson JD, and Ott DE: Capture of antigen-specific T lymphocytes from human blood by selective immortalization to establish long-term T-cell lines maintaining primary cell characteristics. Immunol Lett 2006;105:26-37.
8. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994;68(9):6103-6110.
9. Koup RA, Safrit JT, Cao Y, et al.: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994;68(7):4650-4655.
10. Schmitz JE, Kuroda MJ, Santra S, et al.: Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999;283(5403):857-860.
11. Jin X, Bauer DE, Tuttleton SE, et al.: Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 1999;189(6):991-998.
12. Matano T, Shibata R, Siemon C, Connors M, Lane HC, and Martin MA: Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J Virol 1998;72(1):164-169.
13. Amara RR, Villinger F, Altman JD, et al.: Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 2001;292(5514):69-74.
14. Barouch DH, Santra S, Schmitz JE, et al.: Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 2000;290(5491):486-492.
15. Shiver JW, Fu TM, Chen L, et al.: Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 2002;415(6869):331-335.
16. + lymphocyte depletion on virus containment after simian immunodeficiency virus SIVmac251 challenge of live attenuated SIV-mac239delta3-vaccinated rhesus macaques. J Virol. 2005;79(13): 8131-8141.
17. Lifson JD, Rossio JL, Piatak M Jr, et al.: Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment. J Virol 2001;75(21):10187-10199.
18. Wilson NA, Reed J, Napoe GS, et al.: Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239. J Virol 2006;80(12):5875-5385.
19. Steinert S, White DM, Zou Y, Shay JW, and Wright WE: Telomere biology and cellular aging in nonhuman primate cells. Exp Cell Res 2002;272(2):146-152.
20. Chang WL, Kirchoff V, Pari GS, and Barry PA: Replication of rhesus cytomegalovirus in life-expanded rhesus fibroblasts expressing human telomerase. J Virol Methods 2002;104(2):135-146.
21. Kirchoff V, Wong S, St JS, and Pari GS: Generation of a life-expanded rhesus monkey fibroblast cell line for the growth of rhesus rhadinovirus (RRV). Arch Virol 2002;147(2):321-333.
22. Verzeletti S: Retroviral vector mediated gene transfer into donor peripheral blood lymphocytes for in vitro selection and in vivo immunomodulation of donor anti-tumor immunity after allo-BMT. J Cell Biochem 1995;21A[356 (Abstr. No. C6-007)].
23. Cline AN, Bess JW, Piatak M Jr, and Lifson JD: Highly sensitive SIV plasma viral load assay: Practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS. J Med Primatol 2005;34(5-6):303-312.
24. Mothe BR, Horton H, Carter DK, et al.: Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class 1 molecule during the acute phase of viral infection. J Virol 2002;76(2):875-884.
25. Riddell SR and Greenberg PD: The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells. J Immunol Methods 1990;128(2):189-201.
26. Berger C, Huang ML, Gough M, Greenberg PD, Riddell SR, and Kiem HP: Nonmyeloablative immunosuppressive regimen prolongs in vivo persistence of gene-modified autologous T cells in a nonhuman primate model. J Virol 2001;75(2):799-808.
27. Roederer M: Spectral compensation for flow cytometry: Visualization artifacts, limitations, and caveats. Cytometry 2001;45(3): 194-205.
28. Regier DA and Desrosiers RC: The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus. AIDS Res Hum Retroviruses 1990;6(11):1221-1231.
29. Giavedoni LD: Simultaneous detection of multiple cytokines and chemokines from nonhuman primates using luminex technology. J Immunol Methods 2005;301(1-2):89-101.
30. Battleman DS, Geller AI, and Chao MV: HSV-1 vector-mediated gene transfer of the human nerve growth factor receptor p75hNGFR defines high-affinity NGF binding. J Neurosci 1993;13(3):941-951.
31. Pitcher CJ, Hagen SI, Walker JM, et al.: Development and homeostasis of T cell memory in rhesus macaque. J Immunol 2002;168(1):29-43.
32. Mattapallil JJ, Letvin NL, and Roederer M: T-cell dynamics during acute SIV infection. AIDS 2004;18(1):13-23.
33. Betts MR, Brenchley JM, Price DA, et al.: Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003;281(1-2): 65-78.
34. Dagarag M, Ng H, Lubong R, Effros RB, and Yang OO: Differential impairment of lytic and cytokine functions in senescent human immunodeficiency virus type 1-specific cytotoxic T lymphocytes. J Virol 2003;77(5):3077-3083.
35. + T lymphocytes. Blood 2005;106(8):2663-2670.
36. Harley CB, Fauce SR, Chin AC, Jamieson BD, Yang OO, and Effros RB: Drug candidate TAT0002, a telomerase activator, enhances antiviral functions of HIV-1-specific CD8 T-cells. XVI International AIDS Conference, Toronto, Canada, 2006.
37. Ochsenbein AF, Riddell SR, Brown M, et al.: CD27 expression promotes long-term survival of functional effector-memory CD8+ cytotoxic T lymphocytes in HIV-infected patients. J Exp Med 2004;200(11):1407-1417.
38. Appay V, Dunbar PR, Callan M, et al.: Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002;8(4):379-385.
39. van Baarle D, Kostense S, Hovenkamp E, et al.: Lack of Epstein-Barr virus- and HIV-specific CD27- CD8+ T cells is associated with progression to viral disease in HIV-infection. AIDS 2002;16(15):2001-2011.
40. Kern F, Khatamzas E, Surel I, et al.: Distribution of human CMV-specific memory T cells among the CD8pos. subsets defined by CD57, CD27, and CD45 isoforms. Eur J Immunol 1999-29(9): 2908-2915.
41. Lanzavecchia A and Sallusto F: Understanding the generation and function of memory T cell subsets. Curr Opin Immunol 2005; 17(3):326-332.
42. Baron V, Bouneaud C, Cumano A, et al.: The repertoires of circulating human CD8(+) central and effector memory T cell subsets are largely distinct. Immunity 2003;18(2):193-204.